Skip to Content
  • Previous Rank
    16
  • Revenue 3 Yr Annual Growth Rate
    43%
  • Revenue 3 Yr Growth Rank
    13
  • EPS 3 Yr Annual Growth Rate
    79%
  • EPS 3 Yr Growth Rank
    24
  • Total Return 3 Yr Annual Rate
    13%
  • Total Return 3 Yr Rank
    85

Company Information

Revenue and net income for the four quarters ended on or before April 30, 2019. Total return for the period ended June 28, 2019.
Industry
Pharmaceuticals
Sector
Health Care
Current Streak2
Years on List2
CEO
Scott Tarriff
Websitehttps://www.eagleus.com
Country
U.S.
Headquarters
Woodcliff Lake, N.J.
Ticker
EGRX

Revenue, Net Income

Revenue past four quarters ($M)$216
Net Income past four quarters ($M)$38
Market Value as of June 28, 2019 ($M)$776

Growth Rates and Ranks

Revenue 3 Yr Growth Rank13
Revenue 3 Yr Annual Growth Rate43%
EPS 3 Yr Growth Rank24
EPS 3 Yr Annual Growth Rate79%
Total Return 3 Yr Rank85
Total Return 3 Yr Annual Rate13%
Beat S&P 500 3 Yr Return (14.2%)
no